Search research articles
Contact Us
Filters
Showing results (401-410 of 467) with videos related to
Page
of 47
Sort By:
Neuro-Oncology
|
July 31, 2022
EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors
Roberta Rudà, David Capper, Adam D Waldman, et al.
Nature Medicine
|
August 8, 2022
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
Rupert Bartsch, Anna Sophie Berghoff, Julia Furtner, et al.
Neuro-Oncology
|
June 4, 2019
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management
Farshad Nassiri, Yasin Mamatjan, Suganth Suppiah, et al.
Cancer Medicine
|
March 22, 2022
The cancer survival index-A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies
Alexander Gaiger, Simone Lubowitzki, Katharina Krammer, et al.
Neuro-Oncology
|
August 11, 2022
European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)
Khê Hoang-Xuan, Martina Deckert, Andrés J M Ferreri, et al.
Nature Cell Biology
|
October 2, 2023
Crosstalk between small-cell lung cancer cells and astrocytes mimics brain development to promote brain metastasis
Fangfei Qu, Siqi C Brough, Wojciech Michno, et al.
Cancer Discovery
|
September 20, 2018
Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin
Dian Yang, Sarah K Denny, Peyton G Greenside, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 19, 2024
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0
Nathalie L Albert, Matthias Preusser, Tatjana Traub-Weidinger, et al.
Nature Medicine
|
May 30, 2025
Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial
Matthias Preusser, Javier Garde-Noguera, Juan José García-Mosquera, et al.
The Lancet. Oncology
|
October 30, 2025
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of breast cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial
Rupert Bartsch, Maximilian Marhold, Javier Garde-Noguera, et al.
Page
of 47
Search research articles
Search
Showing results (401-410 of 467) with videos related to
Sort By:
Page
of 47
Neuro-Oncology
|
July 31, 2022
EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors
Roberta Rudà, David Capper, Adam D Waldman, et al.
Nature Medicine
|
August 8, 2022
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial
Rupert Bartsch, Anna Sophie Berghoff, Julia Furtner, et al.
Neuro-Oncology
|
June 4, 2019
DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management
Farshad Nassiri, Yasin Mamatjan, Suganth Suppiah, et al.
Cancer Medicine
|
March 22, 2022
The cancer survival index-A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies
Alexander Gaiger, Simone Lubowitzki, Katharina Krammer, et al.
Neuro-Oncology
|
August 11, 2022
European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL)
Khê Hoang-Xuan, Martina Deckert, Andrés J M Ferreri, et al.
Nature Cell Biology
|
October 2, 2023
Crosstalk between small-cell lung cancer cells and astrocytes mimics brain development to promote brain metastasis
Fangfei Qu, Siqi C Brough, Wojciech Michno, et al.
Cancer Discovery
|
September 20, 2018
Intertumoral Heterogeneity in SCLC Is Influenced by the Cell Type of Origin
Dian Yang, Sarah K Denny, Peyton G Greenside, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 19, 2024
Joint EANM/EANO/RANO/SNMMI practice guideline/procedure standards for diagnostics and therapy (theranostics) of meningiomas using radiolabeled somatostatin receptor ligands: version 1.0
Nathalie L Albert, Matthias Preusser, Tatjana Traub-Weidinger, et al.
Nature Medicine
|
May 30, 2025
Patritumab deruxtecan in leptomeningeal metastatic disease of solid tumors: the phase 2 TUXEDO-3 trial
Matthias Preusser, Javier Garde-Noguera, Juan José García-Mosquera, et al.
The Lancet. Oncology
|
October 30, 2025
Patritumab deruxtecan (HER3-DXd) in patients with active brain metastases of breast cancer (TUXEDO-3): a multicentre, single-arm, phase 2 trial
Rupert Bartsch, Maximilian Marhold, Javier Garde-Noguera, et al.
Page
of 47